Background and aims Endoscopic therapy of gastroesophageal reflux disease (GERD)
overcomes the “treatment gap” for patients with refractory GERD, who are not willing to go …

Background Anti-reflux mucosectomy (ARMS) is a relatively new endoscopic procedure for
gastroesophageal reflux disease (GERD). A hemi-circumferential endoscopic mucosal …

Background Anti-reflux mucosal intervention (ARMI), including anti-reflux mucosectomy
(ARMS) and anti-reflux mucosal ablation (ARMA), is a promising endoscopic treatment for …

Background Anti‐reflux mucosectomy (ARMS) is a newfangled minimally invasive
technique, with successful outcomes for the management of gastroesophageal reflux (GER) …

Background Anti-reflux mucosectomy (ARMS) is a novel endoscopic treatment for refractory
gastroesophageal reflux disease (rGERD). Several studies have validated its safety and …

Background and study aims Antireflux mucosectomy (ARMS) and antireflux mucosal
ablation (ARMA) are new endoscopic procedures for patients with gastroesophageal reflux …

Objectives Some patients with gastroesophageal reflux disease (GERD) are refractory to
proton pump inhibitor (PPI) therapy. Anti‐reflux mucosectomy (ARMS) is a minimally …

Background and study aims Anti-reflux mucosectomy (ARMS) is an emerging endoscopic
treatment for refractory gastroesophageal reflux disease (GERD). We conducted a …

Background and study aims Current endoscopic therapies for gastroesophageal reflux
disorder (GERD) are limited by technical complexity, and/or cost. We sought to evaluate the …

Background Although some kinds of endoluminal surgery for patients with proton pump
inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD) have been reported, there …